What is the maximum dose of Calcium Channel Blockers (CCBs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Doses of Calcium Channel Blockers (CCBs)

The maximum doses of calcium channel blockers vary by specific agent, with amlodipine having a maximum dose of 10 mg daily, nifedipine extended-release 90 mg daily, and verapamil up to 30 mg total for acute use in arrhythmias. 1, 2, 3

Maximum Doses by CCB Class

Dihydropyridine CCBs

  • Amlodipine: Maximum dose 10 mg once daily for adults 1
  • Nifedipine extended-release: Maximum recommended dose 90 mg once daily 2
  • Amlodipine (pediatric): Maximum dose 5 mg daily for children ages 6-17 years 1

Non-dihydropyridine CCBs

  • Verapamil (acute IV use): Maximum total dose of 20-30 mg for treatment of arrhythmias 3
  • Diltiazem (pediatric): Maximum dose 360 mg/day orally 3
  • Amlodipine (pediatric): Maximum dose 10 mg/day orally 3

Special Population Considerations

Hepatic Impairment

  • For patients with hepatic insufficiency, lower starting doses are recommended (e.g., amlodipine 2.5 mg daily) 1
  • Elderly or fragile patients should also be started on lower doses (2.5 mg daily for amlodipine) 1

Cardiovascular Conditions

  • For coronary artery disease, the recommended dose range for amlodipine is 5-10 mg once daily, with most patients requiring 10 mg 1
  • For angina, amlodipine dosing ranges from 5-10 mg daily, with lower doses suggested for elderly and hepatic insufficiency patients 1

Titration Guidelines

  • For amlodipine, titration should generally proceed over 7-14 days between dose adjustments 1
  • For nifedipine extended-release, titration should proceed over a 7-14 day period starting with 30 mg once daily 2
  • More rapid titration may be clinically warranted for amlodipine if the patient is assessed frequently 1

Safety Considerations

  • High doses of dihydropyridine CCBs often cause peripheral edema, headache, flushing, and tachycardia 4
  • High doses of verapamil can cause constipation 4
  • CCBs should be used with caution in patients with left ventricular dysfunction 5
  • Non-dihydropyridine CCBs (verapamil, diltiazem) have stronger negative chronotropic and inotropic effects than dihydropyridines 4, 5
  • Avoid CCBs in patients with heart failure and pre-excited atrial fibrillation or flutter 3

Administration Considerations

  • Nifedipine extended-release tablets should be swallowed whole, not bitten or divided 2
  • Nifedipine should be administered on an empty stomach 2
  • Co-administration of nifedipine with grapefruit juice should be avoided 2
  • Amlodipine can be administered at the most convenient time of day for the patient to improve adherence 6

Remember that dosing should be adjusted according to blood pressure goals and individual patient response, with careful monitoring for side effects, particularly at higher doses 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Calcium channel blockers.

Journal of clinical hypertension (Greenwich, Conn.), 2011

Research

Pharmacological aspects of calcium channel blockers.

Cardiovascular drugs and therapy, 1997

Guideline

Amlodipine Dosing and Management for Hypertension and Coronary Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.